Health ❯Medical Research ❯Neurology

Alzheimer's Disease

Gene Expression Dopamine and Neprilysin Interaction Biomarkers Hypertension IDO1 Inhibitors Phases of Alzheimer's Xenon Treatment Neurovascular Unit Brain Samples

Experimental Drug Shows Potential to Delay Alzheimer's Onset by 50%

A study on gantenerumab highlights early intervention benefits for genetically predisposed individuals, though further research is needed.

Xenon Gas Shows Promise as Potential Alzheimer's Treatment in Mouse Study

New Study Reveals Alzheimer's Progresses in Two Distinct Phases

Cancer Drug Shows Promise in Treating Early-Stage Alzheimer’s

Dopamine Shows Promise in Reducing Alzheimer's Plaques

MIT Study Identifies Key Factors in Alzheimer's Vulnerability and Cognitive Resilience